NAD+ has become one of the most widely discussed molecules in longevity and metabolic research—but what does it actually do?
Short for nicotinamide adenine dinucleotide, NAD+ is a naturally occurring coenzyme found in virtually every living cell. It is not a stimulant and does not supply energy directly. Instead, it helps cells convert nutrients into usable energy and supports enzymes involved in cellular maintenance, stress responses and DNA repair.
Because NAD+ is involved in so many fundamental biological processes, researchers are investigating whether maintaining or restoring NAD+ availability could support healthier cellular function as organisms age.
What is NAD+?
NAD exists mainly in two interchangeable forms:
-
NAD+, the oxidised form
-
NADH, the reduced form
These two forms continuously exchange electrons during metabolic reactions. This redox cycle helps cells extract energy from carbohydrates, fats and proteins and ultimately produce adenosine triphosphate (ATP)—the molecule cells use as their immediate energy currency.
NAD+ also acts as a required substrate for several enzyme families, including sirtuins, poly(ADP-ribose) polymerases (PARPs) and CD38. Through these pathways, NAD+ is connected to gene regulation, DNA-damage responses, cellular stress signalling and immune activity.
Why are NAD+ levels studied in ageing?
Preclinical research has reported that NAD+ availability can decline in multiple tissues with age. Several mechanisms may contribute, including reduced production, increased DNA damage and greater activity of NAD+-consuming enzymes.
This has led researchers to explore a central question: could supporting NAD+ metabolism help ageing cells maintain energy production and repair processes more effectively?
The biology is compelling, but it is important to distinguish a plausible cellular mechanism from a proven health outcome. Raising a biomarker does not automatically mean that a person will feel more energetic, age more slowly or avoid disease. Human research is growing, although results remain mixed and depend on the compound, dose, population and outcome studied.
Potential areas of NAD+ research
1. Cellular energy production
NAD+ is essential to glycolysis, the citric-acid cycle and oxidative phosphorylation—the linked pathways that allow cells to turn food-derived fuel into ATP.
This makes NAD+ particularly relevant to tissues with high energy demands, such as skeletal muscle, the heart and brain. Researchers are studying whether changes in NAD+ metabolism influence cellular energy efficiency, fatigue-related biology and resilience under metabolic stress. It should not, however, be described as an instant energy booster; its role is biochemical and occurs within cellular metabolism.
2. Mitochondrial function
Mitochondria rely on NAD+/NADH reactions to generate ATP. NAD+ is also linked to sirtuin signalling, which can influence mitochondrial adaptation, stress responses and the creation or removal of mitochondria in experimental models.
Animal and cell studies have produced promising findings, but these cannot automatically be applied to humans. Clinical trials of NAD+ precursors have generally shown that certain compounds can alter NAD-related metabolites, while consistent improvements in physical performance or metabolic health have not yet been established across populations.
3. DNA repair and cellular maintenance
Everyday metabolism and environmental exposures continually damage DNA. PARP enzymes use NAD+ when coordinating parts of the DNA-damage response.
When DNA damage is extensive, PARP activity can consume substantial amounts of NAD+. This relationship has made NAD+ an important subject in research into genomic stability, cellular stress and ageing. NAD+ supports the machinery involved in these processes, but this does not mean that an NAD+ product has been proven to repair DNA or prevent disease in people.
4. Sirtuins and healthy-ageing pathways
Sirtuins are NAD+-dependent enzymes involved in metabolic regulation, gene expression and responses to cellular stress. Their reliance on NAD+ is one reason the molecule is so prominent in longevity research.
In laboratory models, changing NAD+ availability can affect sirtuin activity and several pathways associated with ageing. Whether these changes produce meaningful longevity benefits in healthy humans remains unknown. There is currently no good clinical evidence that NAD+ or an NAD+ precursor extends human lifespan.
5. Metabolic health
NAD+ metabolism is closely connected to glucose handling, fat oxidation and insulin signalling. Early human studies of precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) have reported changes in NAD-related biomarkers, and some small trials have found benefits in specific metabolic measurements.
These findings are preliminary. They should be viewed as a reason for further controlled research—not proof that all NAD+-related compounds cause weight loss, treat diabetes or improve metabolic health.
6. Muscle function and exercise research
Muscle cells require efficient mitochondrial metabolism to sustain movement and recover from energetic stress. For this reason, NAD+ pathways are being studied in relation to muscle ageing, endurance and recovery.
Human trial results have been inconsistent. Some studies report changes in molecular or inflammatory markers without corresponding improvements in strength, exercise capacity or body composition. More research is required to establish which participants, if any, are most likely to benefit.
7. Brain and nervous-system research
Neurons have high energy requirements and depend on strong mitochondrial and DNA-maintenance systems. NAD+ biology is therefore being investigated in models of neurodegeneration, axonal injury and cognitive ageing.
Most disease-specific claims remain based on preclinical or early-stage work. NAD+ should not be presented as a treatment for memory loss, neurological disease, anxiety or depression.
NAD+ compared with NAD+ precursors
NAD+, NR, NMN, niacin and nicotinamide are related, but they are not identical or interchangeable.
-
NAD+ is the coenzyme used directly in cellular reactions.
-
NR and NMN are precursors that cells may use to produce NAD+.
-
Niacin and nicotinamide are forms of vitamin B3 that also contribute to NAD+ synthesis through different biochemical routes.
Research findings for one compound should not automatically be used to advertise another. Their absorption, metabolism, delivery routes, safety profiles and supporting evidence can differ.
What does the human evidence currently show?
Human trials indicate that certain NAD+ precursors can increase NAD-related metabolites in blood or tissues under particular conditions. That is an important proof of biological activity.
The larger question—whether these biochemical changes reliably translate into noticeable improvements in energy, cognition, exercise performance, metabolic health or lifespan—remains unresolved. Many trials have been small, short in duration or focused on specific populations, and results have not always been consistent.
The most scientifically accurate conclusion is that NAD+ metabolism is a highly important and promising field of research, while broad anti-ageing and therapeutic claims currently run ahead of the clinical evidence.
The future of NAD+ research
Future studies will need to determine:
-
which NAD+-related compounds most effectively reach specific tissues;
-
which biomarkers best reflect meaningful biological effects;
-
whether age, health status or baseline NAD+ levels influence response;
-
the doses and exposure periods appropriate for different research questions; and
-
whether long-term changes in NAD+ metabolism produce clinically meaningful outcomes.
As better-controlled and longer-duration human trials are completed, researchers should gain a clearer picture of where NAD+ support is useful—and where promising laboratory mechanisms do not translate into real-world benefits.
Final thoughts
NAD+ sits at the intersection of cellular energy, mitochondrial function, DNA-damage responses and metabolic regulation. That makes it a genuinely important molecule—not merely a wellness trend.
Its strongest established “benefit” is its fundamental role in normal cellular biology. Research into raising NAD+ availability is exciting, but proposed benefits such as improved performance, disease prevention and slower human ageing still require stronger clinical confirmation.
At Biolabs Research, we believe responsible scientific exploration begins with accurate information, clear limitations and careful separation of experimental findings from proven outcomes.
Research-use notice
Biolabs Research products are supplied strictly for laboratory research and analytical purposes. They are not medicines and are not intended to diagnose, treat, cure or prevent any disease, nor for human or veterinary consumption. This article is educational and does not constitute medical advice.
Selected research
-
Cantó C, et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metabolism. 2012. https://pubmed.ncbi.nlm.nih.gov/22682224/
-
Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018. https://pubmed.ncbi.nlm.nih.gov/29599478/
-
Dollerup OL, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men. American Journal of Clinical Nutrition. 2018. https://pubmed.ncbi.nlm.nih.gov/29992272/
-
Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021. https://pubmed.ncbi.nlm.nih.gov/33888596/
-
Elhassan YS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports. 2019. https://pubmed.ncbi.nlm.nih.gov/31412242/